QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
Log in
OTCMKTS:RGIN

Regenicin Stock Forecast, Price & News

$0.01
0.00 (-3.23 %)
(As of 09/30/2020 11:31 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.01
52-Week Range
$0.00
Now: $0.01
$0.03
Volume20,000 shs
Average Volume50,786 shs
Market Capitalization$1.85 million
P/E RatioN/A
Dividend YieldN/A
Beta0.73
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. Its development products include NovaDerm, a cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was founded in 2007 and is based in Little Falls, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RGIN
CUSIPN/A
Phone973-557-8914

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.02) per share

Profitability

Net Income$-760,000.00
Return on Assets-15,381.87%

Miscellaneous

Employees3
Market Cap$1.85 million
Next Earnings Date11/18/2020 (Estimated)
OptionableNot Optionable
$0.01
0.00 (-3.23 %)
(As of 09/30/2020 11:31 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RGIN News and Ratings via Email

Sign-up to receive the latest news and ratings for RGIN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Regenicin (OTCMKTS:RGIN) Frequently Asked Questions

How has Regenicin's stock price been impacted by Coronavirus?

Regenicin's stock was trading at $0.0185 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RGIN stock has decreased by 35.1% and is now trading at $0.0120.
View which stocks have been most impacted by COVID-19
.

When is Regenicin's next earnings date?

Regenicin is scheduled to release its next quarterly earnings announcement on Wednesday, November 18th 2020.
View our earnings forecast for Regenicin
.

How were Regenicin's earnings last quarter?

Regenicin Inc (OTCMKTS:RGIN) announced its earnings results on Wednesday, August, 19th. The company reported $0.00 earnings per share (EPS) for the quarter.
View Regenicin's earnings history
.

Who are some of Regenicin's key competitors?

What other stocks do shareholders of Regenicin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Amarantus Bioscience (AMBS), Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), Cheniere Energy (LNG), Horsehead (ZINCQ), Ambarella (AMBA) and Alstom (ALO).

Who are Regenicin's key executives?

Regenicin's management team includes the following people:
  • Mr. Randall McCoy, Chairman, CEO & Pres (Age 70)
  • Mr. John J. Weber, CFO & Director (Age 69)
  • Dr. J. Roy Nelson, Chief Science Officer (Age 71)

What is Regenicin's stock symbol?

Regenicin trades on the OTCMKTS under the ticker symbol "RGIN."

How do I buy shares of Regenicin?

Shares of RGIN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Regenicin's stock price today?

One share of RGIN stock can currently be purchased for approximately $0.01.

How big of a company is Regenicin?

Regenicin has a market capitalization of $1.85 million. Regenicin employs 3 workers across the globe.

What is Regenicin's official website?

The official website for Regenicin is www.regenicin.com.

How can I contact Regenicin?

Regenicin's mailing address is 10 HIGH COURT, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-557-8914.

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.